Suchergebnisse - "Follmann, Dean"

PubPharm (42)

1

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome

enthalten in: The Journal of clinical investigation | 2023

von McDermott, D. | Velez, D. | Cho, E. | +17

2

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

enthalten in: Viruses | 2023

von Huang, Y. | Hejazi, N. | Blette, B. | +41

3

Modifiers of COVID-19 vaccine efficacy : Results from four COVID-19 prevention network efficacy trials

enthalten in: Vaccine | 2023

von Turley, C. | Tables, L. | Fuller, T. | +33

4

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

enthalten in: Nature communications | 2023

von Follmann, D. | O'Brien, M. | Fintzi, J. | +21

5

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

enthalten in: Science translational medicine | 2023

von Benkeser, D. | Montefiori, D. | McDermott, A. | +46

6

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

enthalten in: Nature communications | 2023

von Fong, Y. | Huang, Y. | Benkeser, D. | +37

ErratumIn: Nat Commun. 2023 Mar 22;14(1):1581. - PMID 36949083

7

Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials

enthalten in: JAMA network open | 2023

von Mena Lora, A. | Long, J. | Huang, Y. | +125

ErratumIn: JAMA Netw Open. 2023 May 1;6(5):e2317317. - PMID 37213108

8

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

enthalten in: Nature microbiology | 2022

von Fong, Y. | McDermott, A. | Benkeser, D. | +58

UpdateOf: medRxiv. 2022 Apr 12;:. - PMID 35441174

9

Anti-PF4 antibodies associated with disease severity in COVID-19

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Liu, Q. | Miao, H. | Li, S. | +16

10

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

enthalten in: Annals of internal medicine | 2022

von Follmann, D. | Janes, H. | Buhule, O. | +10

1
2
3
4
5
Nächster »
[5]